A Multi-center Cohort Study of Hydatidiform Mole in China (CN-HM-01)

Key facts

Sponsor

Obstetrics & Gynecology Hospital of Fudan University

Principal Investigator

Xin Lu, MD & PhD, MD

Obstetrics & Gynecology Hospital of Fudan University

Intervention

No intervention(other)

Enrollment

1489 enrolled

Eligibility

18-60 years · FEMALE

Timeline

2025 – 2030

Study locations (14)

• Gansu Province Maternal and Child Care Hospital, Lanzhou, Gansu, China
• Shenzhen Maternity & Child Healthcare Hospital, Shenzhen, Guangdong, China
• Hainan women and children medical center, Haikou, Hainan, China
• Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China
• Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
• Dalian Women and Children medical Center, Dalian, Liaoning, China
• Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
• Center for Reproductive Medicine, Shandong University, Jinan, Shandong, China
• The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
• Shanghai First Maternity and Infant Hospital, Shanghai, Shandong, China
• Obstetrics & Gynecology Hospital of Fudan University, Shanghai, Shanghai Municipality, China
• First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China
• Peking Union Medical College Hospital, Beijing, China
• International Peace Maternity and Child Health Hospital, Shanghai, China

Collaborators

Peking Union Medical College Hospital · Shengjing Hospital · Hebei Medical University Third Hospital · Hainan women and children medical center · Shenzhen Maternity & Child Healthcare Hospital · Third Affiliated Hospital of Zhengzhou University · Shanghai First Maternity and Infant Hospital · International Peace Maternity and Child Health Hospital · Shandong University · First Affiliated Hospital of Zhejiang University · The Affiliated Hospital of Qingdao University · Gansu Provincial Maternity and Child-care Hospital/Gansu Provincial Central Hospital · Dalian women and children's medical group

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.